Nivolumab in Biochemically Recurrent dMMR Prostate Cancer

NCT04019964 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Recurrent Prostate Cancer

Interventions

DRUG: Nivolumab

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]